- Home
- MNY vs FGEN Comparison
MNY vs FGEN Comparison
Compare MNY & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- FGEN
- Stock Information
- Founded
- MNY 2014
- FGEN 1993
- Country
- MNY Singapore
- FGEN United States
- Employees
- MNY N/A
- FGEN N/A
- Industry
- MNY
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- FGEN Health Care
- Exchange
- MNY Nasdaq
- FGEN Nasdaq
- Market Cap
- MNY 30.4M
- FGEN 33.5M
- IPO Year
- MNY N/A
- FGEN 2014
- Fundamental
- Price
- MNY $0.78
- FGEN $0.30
- Analyst Decision
- MNY
- FGEN Strong Buy
- Analyst Count
- MNY 0
- FGEN 1
- Target Price
- MNY N/A
- FGEN $10.00
- AVG Volume (30 Days)
- MNY 28.1K
- FGEN 561.8K
- Earning Date
- MNY 06-23-2025
- FGEN 05-12-2025
- Dividend Yield
- MNY N/A
- FGEN N/A
- EPS Growth
- MNY N/A
- FGEN N/A
- EPS
- MNY N/A
- FGEN N/A
- Revenue
- MNY $79,511,000.00
- FGEN $6,996,000.00
- Revenue This Year
- MNY $31.98
- FGEN $232.81
- Revenue Next Year
- MNY $10.97
- FGEN $9.16
- P/E Ratio
- MNY N/A
- FGEN N/A
- Revenue Growth
- MNY N/A
- FGEN N/A
- 52 Week Low
- MNY $0.55
- FGEN $0.18
- 52 Week High
- MNY $2.75
- FGEN $1.74
- Technical
- Relative Strength Index (RSI)
- MNY 52.46
- FGEN 44.82
- Support Level
- MNY $0.70
- FGEN $0.29
- Resistance Level
- MNY $0.79
- FGEN $0.32
- Average True Range (ATR)
- MNY 0.05
- FGEN 0.02
- MACD
- MNY 0.00
- FGEN 0.00
- Stochastic Oscillator
- MNY 59.50
- FGEN 26.53
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.